{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:15:04Z","timestamp":1793146504288,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T00:00:00Z","timestamp":1490572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s11920-017-0775-9","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T08:48:14Z","timestamp":1490604494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":438,"title":["Cannabis, Cannabinoids, and Sleep: a Review of the Literature"],"prefix":"10.1007","volume":"19","author":[{"given":"Kimberly A.","family":"Babson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Sottile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"key":"775_CR1","unstructured":"Marijuana (Cannabis): Substance Abuse and Mental Health Services Administration; 2016 [Available from: https:\/\/www.samhsa.gov\/atod\/marijuana ."},{"issue":"1","key":"775_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/00952990.2013.821477","volume":"40","author":"MO Bonn-Miller","year":"2014","unstructured":"\u2022 Bonn-Miller MO, Boden MT, Bucossi MM, Babson KA. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse. 2014;40(1):23\u201330. This study examined medical cannabis patients' demographic profiles, reported reasons for using cannabis, and patterns of use.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"775_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389\u2013462.","journal-title":"Pharmacol Rev"},{"key":"775_CR4","volume-title":"Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential","author":"F Grotenhermen","year":"2002","unstructured":"Grotenhermen F, Russo E. Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential. New York: Haworth Press Inc; 2002."},{"issue":"4","key":"775_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/BF00437513","volume":"33","author":"K Cousens","year":"1973","unstructured":"Cousens K, DiMascio A. (\u2212) Delta 9 THC as an hypnotic. An experimental study of three dose levels. Psychopharmacologia. 1973;33(4):355\u201364.","journal-title":"Psychopharmacologia"},{"issue":"3","key":"775_CR6","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/cpt1972133426","volume":"13","author":"RT Pivik","year":"1972","unstructured":"Pivik RT, Zarcone V, Dement WC, Hollister LE. Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns. Clin Pharmacol Ther. 1972;13(3):426\u201335.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"775_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/cpt1975174458","volume":"17","author":"I Feinberg","year":"1975","unstructured":"Feinberg I, Jones R, Walker JM, Cavness C, March J. Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man. Clin Pharmacol Ther. 1975;17(4):458\u201366.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"775_CR8","first-page":"47","volume":"8","author":"ES Barratt","year":"1974","unstructured":"Barratt ES, Beaver W, White R. The effects of marijuana on human sleep patterns. Biol Psychiatry. 1974;8(1):47\u201354.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"775_CR9","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1002\/cpt1976196782","volume":"19","author":"I Feinberg","year":"1976","unstructured":"Feinberg I, Jones R, Walker J, Cavness C, Floyd T. Effects of marijuana extract and tetrahydrocannabinol on electroencephalographic sleep patterns. Clin Pharmacol Ther. 1976;19(6):782\u201394.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"775_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/BF02244601","volume":"100","author":"LD Chait","year":"1990","unstructured":"Chait LD. Subjective and behavioral effects of marijuana the morning after smoking. Psychopharmacology. 1990;100(3):328\u201333.","journal-title":"Psychopharmacology"},{"issue":"4","key":"775_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/0376-8716(82)90036-9","volume":"10","author":"FR Freemon","year":"1982","unstructured":"Freemon FR. The effect of chronically administered delta-9-tetrahydrocannabinol upon the polygraphically monitored sleep of normal volunteers. Drug Alcohol Depend. 1982;10(4):345\u201353.","journal-title":"Drug Alcohol Depend"},{"key":"775_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1749-6632.1976.tb49909.x","volume":"282","author":"I Karacan","year":"1976","unstructured":"Karacan I, Fernandez-Salas A, Coggins WJ, Carter WE, Williams RL, Thornby JI, et al. Sleep electroencephalographic-electrooculographic characteristics of chronic marijuana users: part I. Ann N Y Acad Sci. 1976;282:348\u201374.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"775_CR13","first-page":"28","volume":"60","author":"K Pranikoff","year":"1973","unstructured":"Pranikoff K, Karacan I, Larson EA, Williams RL, Thornby JI, Hursch CJ. Effects of marijuana smoking on the sleep EEG. Preliminary studies JFMA. 1973;60(3):28\u201331.","journal-title":"Preliminary studies JFMA"},{"issue":"4","key":"775_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jsat.2008.01.002","volume":"35","author":"AJ Budney","year":"2008","unstructured":"Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z. Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J Subst Abus Treat. 2008;35(4):362\u20138.","journal-title":"J Subst Abus Treat"},{"issue":"11","key":"775_CR15","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1016\/j.addbeh.2013.06.012","volume":"38","author":"KA Babson","year":"2013","unstructured":"Babson KA, Boden MT, Bonn-Miller MO. The impact of perceived sleep quality and sleep efficiency\/duration on cannabis use during a self-guided quit attempt. Addict Behav. 2013;38(11):2707\u201313.","journal-title":"Addict Behav"},{"issue":"4","key":"775_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jsat.2012.08.224","volume":"44","author":"KA Babson","year":"2013","unstructured":"Babson KA, Boden MT, Harris AH, Stickle TR, Bonn-Miller MO. Poor sleep quality as a risk factor for lapse following a cannabis quit attempt. J Subst Abus Treat. 2013;44(4):438\u201343.","journal-title":"J Subst Abus Treat"},{"issue":"1","key":"775_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/10550490500418997","volume":"15","author":"ML Copersino","year":"2006","unstructured":"Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, et al. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict. 2006;15(1):8\u201314.","journal-title":"Am J Addict"},{"issue":"1","key":"775_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1369-1600.2008.00121.x","volume":"14","author":"M Haney","year":"2009","unstructured":"Haney M. Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls. Addict Biol. 2009;14(1):9\u201321.","journal-title":"Addict Biol"},{"issue":"1","key":"775_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.drugalcdep.2011.01.003","volume":"117","author":"R Vandrey","year":"2011","unstructured":"Vandrey R, Smith MT, McCann UD, Budney AJ, Curran EM. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal. Drug Alcohol Depend. 2011;117(1):38\u201344.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"775_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1037\/0021-843X.112.3.393","volume":"112","author":"AJ Budney","year":"2003","unstructured":"Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112(3):393\u2013402.","journal-title":"J Abnorm Psychol"},{"issue":"1","key":"775_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0376-8716(98)00003-9","volume":"50","author":"TJ Crowley","year":"1998","unstructured":"Crowley TJ, Macdonald MJ, Whitmore EA, Mikulich SK. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend. 1998;50(1):27\u201337.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"775_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.drugalcdep.2004.11.001","volume":"78","author":"R Vandrey","year":"2005","unstructured":"Vandrey R, Budney AJ, Kamon JL, Stanger C. Cannabis withdrawal in adolescent treatment seekers. Drug Alcohol Depend. 2005;78(2):205\u201310.","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20133","key":"775_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2007.06.010","volume":"92","author":"RG Vandrey","year":"2008","unstructured":"Vandrey RG, Budney AJ, Hughes JR, Liguori A. A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug Alcohol Depend. 2008;92(1\u20133):48\u201354.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"775_CR24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.sleep.2010.02.013","volume":"11","author":"KI Bolla","year":"2010","unstructured":"Bolla KI, Lesage SR, Gamaldo CE, Neubauer DN, Wang NY, Funderburk FR, et al. Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence. Sleep Med. 2010;11(9):882\u20139.","journal-title":"Sleep Med"},{"key":"775_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainres.2008.05.048","volume":"1222","author":"AE Sanford","year":"2008","unstructured":"Sanford AE. Cannabinoids and hamster circadian activity rhythms. Brain Res. 2008;1222:141\u20138.","journal-title":"Brain Res"},{"issue":"3","key":"775_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1476-5381.2010.00790.x","volume":"160","author":"LK Vaughn","year":"2010","unstructured":"Vaughn LK, Denning G, Stuhr KL, de Wit H, Hill MN, Hillard CJ. Endocannabinoid signalling: has it got rhythm? Br J Pharmacol. 2010;160(3):530\u201343.","journal-title":"Br J Pharmacol"},{"issue":"17","key":"775_CR27","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1097\/00001756-200112040-00038","volume":"12","author":"RR Perron","year":"2001","unstructured":"Perron RR, Tyson RL, Sutherland GR. Delta9-tetrahydrocannabinol increases brain temperature and inverts circadian rhythms. Neuroreport. 2001;12(17):3791\u20134.","journal-title":"Neuroreport"},{"issue":"3","key":"775_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","volume":"24","author":"AN Nicholson","year":"2004","unstructured":"Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol. 2004;24(3):305\u201313.","journal-title":"J Clin Psychopharmacol"},{"issue":"8\u20139 Suppl","key":"775_CR29","doi-asserted-by":"publisher","first-page":"417S","DOI":"10.1002\/j.1552-4604.1981.tb02622.x","volume":"21","author":"EA Carlini","year":"1981","unstructured":"Carlini EA, Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 1981;21(8\u20139 Suppl):417S\u201327S.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"775_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","volume":"30","author":"AW Zuardi","year":"2008","unstructured":"Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr. 2008;30(3):271\u201380.","journal-title":"Rev Bras Psiquiatr"},{"issue":"12","key":"775_CR31","first-page":"0","volume":"4","author":"R Tringale","year":"2011","unstructured":"Tringale R, Jensen C. Cannabis and insomnia. Depression. 2011;4(12):0\u201368.","journal-title":"Depression"},{"issue":"1","key":"775_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2011.08.013","volume":"62","author":"YT Hsiao","year":"2012","unstructured":"Hsiao YT, Yi PL, Li CL, Chang FC. Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats. Neuropharmacology. 2012;62(1):373\u201384.","journal-title":"Neuropharmacology"},{"issue":"3","key":"775_CR33","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/0269881112474524","volume":"27","author":"MH Chagas","year":"2013","unstructured":"Chagas MH, Crippa JA, Zuardi AW, Hallak JE, Machado-de-Sousa JP, Hirotsu C, et al. Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. J Psychopharmacol. 2013;27(3):312\u20136.","journal-title":"J Psychopharmacol"},{"issue":"5","key":"775_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1521-0391.2013.12003.x","volume":"22","author":"DA Gorelick","year":"2013","unstructured":"Gorelick DA, Goodwin RS, Schwilke E, Schroeder JR, Schwope DM, Kelly DL, et al. Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers. Am J Addict. 2013;22(5):510\u20134.","journal-title":"Am J Addict"},{"key":"775_CR35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.addbeh.2015.06.032","volume":"50","author":"KA Belendiuk","year":"2015","unstructured":"\u2022 Belendiuk KA, Babson KA, Vandrey R, Bonn-Miller MO. Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. Addict Behav. 2015;50:178. This article documented the preferred cannabis strain and cannabinoid concentration among a group of medical cannabis users reporting use of cannabis for insomnia and nightmares.","journal-title":"Addict Behav"},{"issue":"5","key":"775_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/hup.2483","volume":"30","author":"R Ogeil","year":"2015","unstructured":"\u2022 Ogeil R, Phillips JG, Rajaratnam SM, Broadbear JH. Risky drug use and effects on sleep quality and daytime sleepiness. Hum Psychopharmacol Clin Exp. 2015;30(5):356\u201363. This study investigated sleep disturbance among a sample of problematic alcohol and cannabis users and found impaired sleep quality to be a larger problem than excessive daytime sleepiness.","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"4","key":"775_CR37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7812\/TPP\/16-005","volume":"20","author":"S Shannon","year":"2016","unstructured":"Shannon S, Opila-Lehman J. Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report. Perm J. 2016;20(4):108\u201311.","journal-title":"Perm J"},{"issue":"4","key":"775_CR38","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/sleep\/25.4.388","volume":"25","author":"DW Carley","year":"2002","unstructured":"Carley DW, Paviovic S, Janelidze M, Radulovacki M. Functional role for cannabinoids in respiratory stability during sleep. Sleep. 2002;25(4):391\u20138.","journal-title":"Sleep"},{"issue":"9","key":"775_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1055\/s-0030-1253344","volume":"118","author":"R Jumpertz","year":"2010","unstructured":"Jumpertz R, Wiesner T, Bluher M, Engeli S, Batkai S, Wirtz H, et al. Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea\u2014specific role of oleoylethanolamide. Exp Clin Endocrinol Diabetes. 2010;118(9):591\u20135.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"775_CR40","first-page":"1","volume":"4","author":"B Prasad","year":"2013","unstructured":"Prasad B, Radulovacki MG, Carley DW. Proof of concept trial of dronabinol in obstructive sleep apnea. Front Psychiatry. 2013;4:1.","journal-title":"Front Psychiatry"},{"key":"775_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.resp.2013.10.001","volume":"190","author":"MW Calik","year":"2014","unstructured":"\u2022 Calik MW, Radulovacki M, Carley DW. Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat. Respir Physiol Neurobiol. 2014;190:20\u20134. This study examined the effect of synthetic cannabinoid injections into the nodose ganglion of rats and found that this treatment reduced symptoms of OSA.","journal-title":"Respir Physiol Neurobiol"},{"issue":"1","key":"775_CR42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5664\/jcsm.3358","volume":"10","author":"SS Farabi","year":"2014","unstructured":"\u2022 Farabi SS, Prasad B, Quinn L, Carley DW. Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome. J Clin Sleep Med. 2014;10(1):49\u201356. This study investigated dronabinol's effect on delta and theta wave activity and ultradian rhythms as measured by polysomnography.","journal-title":"J Clin Sleep Med"},{"key":"775_CR43","doi-asserted-by":"publisher","unstructured":"\u2022 Calik MW, Radulovacki M, Carley DW. A method of nodose ganglia injection in Sprague-Dawley rat. J Vis Exp. 2014(93):e52233. This article describes a technique for localized injection into the nodose ganglia of rats to prevent central nervous system alteration and isolate peripheral nervous system activity.","DOI":"10.3791\/52233"},{"key":"775_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12952-016-0052-1","volume":"15","author":"MW Calik","year":"2016","unstructured":"\u2022 Calik MW, Carley DW. Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats. J Negat Results Biomed. 2016;15:8. This study examined the effect of central nervous system injections of a synthetic cannabinoid and determined that the drug's ability to reduce apneas is a result of peripheral rather than central nervous system activation.","journal-title":"J Negat Results Biomed"},{"issue":"5","key":"775_CR45","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/jcpt.12179","volume":"39","author":"MH Chagas","year":"2014","unstructured":"\u2022 Chagas MH, Eckeli AL, Zuardi AW, Pena-Pereira MA, Sobreira-Neto MA, Sobreira ET, et al. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series. J Clin Pharm Ther. 2014;39(5):564\u20136. This article documented cannabidiol's effect in reducing REM sleep behavior disorder symptoms among a sample of patients with Parkinson's disease.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"775_CR46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","volume":"15","author":"GA Fraser","year":"2009","unstructured":"Fraser GA. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD). CNS Neurosci Ther. 2009;15(1):84\u20138.","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"775_CR47","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/JCP.0000000000000180","volume":"34","author":"C Cameron","year":"2014","unstructured":"\u2022 Cameron C, Watson D, Robinson J. Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation. J Clin Psychopharmacol. 2014;34(5):559\u201364. This study examined the use of Nabilone in a correctional facility and found that the drug reduced nightmares associated with PTSD.","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"775_CR48","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40261-014-0212-3","volume":"34","author":"P Roitman","year":"2014","unstructured":"\u2022 Roitman P, Mechoulam R, Cooper-Kazaz R, Shalev A. Preliminary, open-label, pilot study of add-on oral Delta9-tetrahydrocannabinol in chronic post-traumatic stress disorder. Clin Drug Investig. 2014;34(8):587\u201391. This article provided prelimary evidence suggesting that THC may be effective in reducing nightmares and improving sleep quality among patients with PTSD.","journal-title":"Clin Drug Investig"},{"key":"775_CR49","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","volume":"51","author":"R Jetly","year":"2015","unstructured":"\u2022 Jetly R, Heber A, Fraser G, Boisvert D. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study. Psychoneuroendocrinology. 2015;51:585\u20138. This article provided preliminary evidence suggesting that Nabilone may be effective in reducing nightmares associated with PTSD.","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"775_CR50","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","volume":"110","author":"MA Ware","year":"2010","unstructured":"Ware MA, Fitzcharles MA, Joseph L, Shir Y. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial. Anesth Analg. 2010;110(2):604\u201310.","journal-title":"Anesth Analg"},{"issue":"2","key":"775_CR51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5664\/jcsm.4448","volume":"11","author":"S Dzodzomenyo","year":"2015","unstructured":"\u2022 Dzodzomenyo S, Stolfi A, Splaingard D, Earley E, Onadeko O, Splaingard M. Urine toxicology screen in multiple sleep latency test: the correlation of positive tetrahydrocannabinol, drug negative patients, and narcolepsy. J Clin Sleep Med. 2015;11(2):93\u20139. This study investigated the relationship between positive urine screen for THC and presence of excessive daytime sleepiness and narcolepsy among a pediatric patient population.","journal-title":"J Clin Sleep Med"},{"key":"775_CR52","doi-asserted-by":"publisher","unstructured":"Association AP. Diagnostic and statistical manual of mental disorders (5th ed.). Washington 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"3","key":"775_CR53","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.sleep.2014.12.008","volume":"16","author":"ES Ford","year":"2015","unstructured":"\u2022 Ford ES, Cunningham TJ, Giles WH, Croft JB. Trends in insomnia and excessive daytime sleepiness among U.S. adults from 2002 to 2012. Sleep Med. 2015;16(3):372\u20138. This study examined prevalence of insomnia and daytime sleepiness based on National Health Interview survey data.","journal-title":"Sleep Med"},{"issue":"6","key":"775_CR54","first-page":"31","volume":"14","author":"S Shannon","year":"2015","unstructured":"\u2022 Shannon S, Opila-Lehman J. Cannabidiol oil for decreasing addictive use of marijuana: a case report. Integr Med (Encinitas). 2015;14(6):31\u20135. This case study investigated cannabidiol's effect on problematic cannabis use, anxiety, and sleep disturbance and found benefits for all three conditions.","journal-title":"Integr Med (Encinitas)"},{"issue":"1","key":"775_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jat\/bks081","volume":"37","author":"DA Gorelick","year":"2013","unstructured":"Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, et al. Tolerance to effects of high-dose oral delta9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers. J Anal Toxicol. 2013;37(1):11\u20136.","journal-title":"J Anal Toxicol"},{"issue":"9","key":"775_CR56","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/aje\/kws342","volume":"177","author":"PE Peppard","year":"2013","unstructured":"Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006\u201314.","journal-title":"Am J Epidemiol"},{"key":"775_CR57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2147\/NSS.S46818","volume":"6","author":"TE Weaver","year":"2014","unstructured":"\u2022 Weaver TE, Calik MW, Farabi SS, Fink AM, Galang-Boquiren MT, Kapella MC, et al. Innovative treatments for adults with obstructive sleep apnea. Nat Sci Sleep. 2014;6:137\u201347. This article provided a review of novel treatment approaches for OSA including surgical, mechanical, and pharmacotherapy treatments.","journal-title":"Nat Sci Sleep"},{"issue":"2","key":"775_CR58","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1164\/ajrccm.153.2.8564132","volume":"153","author":"SC Veasey","year":"1996","unstructured":"Veasey SC, Panckeri KA, Hoffman EA, Pack AI, Hendricks JC. The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am J Respir Crit Care Med. 1996;153(2):776\u201386.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"775_CR59","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.sleep.2012.09.018","volume":"14","author":"SJ McCarter","year":"2013","unstructured":"McCarter SJ, Boswell CL, St Louis EK, Dueffert LG, Slocumb N, Boeve BF, et al. Treatment outcomes in REM sleep behavior disorder. Sleep Med. 2013;14(3):237\u201342.","journal-title":"Sleep Med"},{"issue":"4","key":"775_CR60","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5664\/jcsm.27883","volume":"6","author":"RN Aurora","year":"2010","unstructured":"Aurora RN, Zak RS, Auerbach SH, Casey KR, Chowdhuri S, Karippot A, et al. Best practice guide for the treatment of nightmare disorder in adults. J Clin Sleep Med. 2010;6(4):389\u2013401.","journal-title":"J Clin Sleep Med"},{"issue":"9","key":"775_CR61","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1176\/appi.ajp.2013.12081133","volume":"170","author":"MA Raskind","year":"2013","unstructured":"Raskind MA, Peterson K, Williams T, Hoff DJ, Hart K, Holmes H, et al. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry. 2013;170(9):1003\u201310.","journal-title":"Am J Psychiatry"},{"issue":"15","key":"775_CR62","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2146\/ajhp140523","volume":"72","author":"K Betthauser","year":"2015","unstructured":"\u2022 Betthauser K, Pilz J, Vollmer LE. Use and effects of cannabinoids in military veterans with posttraumatic stress disorder. Am J Health Syst Pharm. 2015;72(15):1279\u201384. This study investigated the use of cannabinoids by military veterans with PTSD and found that cannabis use was associated with a decrease in nightmares associated with PTSD.","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"775_CR63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11481-015-9600-6","volume":"10","author":"ME Lynch","year":"2015","unstructured":"\u2022 Lynch ME, Ware MA. Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials. J NeuroImmune Pharmacol. 2015;10(2):293\u2013301. This article provided a literature review of research investigating the use of cannabinoids in treating chronic pain.","journal-title":"J NeuroImmune Pharmacol"},{"issue":"8","key":"775_CR64","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/cbdv.200790150","volume":"4","author":"EB Russo","year":"2007","unstructured":"Russo EB, Guy GW, Robson PJ. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers. 2007;4(8):1729\u201343.","journal-title":"Chem Biodivers"},{"issue":"2","key":"775_CR65","first-page":"191","volume":"4","author":"G Ferguson","year":"2015","unstructured":"\u2022 Ferguson G, Ware M. Review article: sleep, pain and cannabis. Journal of Sleep Disorders & Therapy. 2015;4(2):191. This paper reviewed the state of current research on cannabis, chronic pain, and sleep.","journal-title":"Journal of Sleep Disorders & Therapy"},{"issue":"9","key":"775_CR66","doi-asserted-by":"publisher","first-page":"e1145","DOI":"10.4088\/JCP.14019tx1c","volume":"76","author":"T Roth","year":"2015","unstructured":"\u2022 Roth T. Effects of excessive daytime sleepiness and fatigue on overall health and cognitive function. J Clin Psychiatry. 2015;76(9):e1145. This article described the negative health effects of excessive daytime sleepiness and discussed psychometric scales used to measure excessive daytime sleepiness.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"775_CR67","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/1570159X11666131204235805","volume":"12","author":"E Murillo-Rodriguez","year":"2014","unstructured":"\u2022 Murillo-Rodriguez E, Sarro-Ramirez A, Sanchez D, Mijangos-Moreno S, Tejeda-Padron A, Poot-Ake A, et al. Potential effects of cannabidiol as a wake-promoting agent. Curr Neuropharmacol. 2014;12(3):269\u201372. This study examined the effects of cannabidiol as a wakefulness promoting drug.","journal-title":"Curr Neuropharmacol"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-017-0775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-017-0775-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-017-0775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T22:29:57Z","timestamp":1658874597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-017-0775-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1007\/s11920-017-0775-9","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,27]]},"article-number":"23"}}